Explor Endocr Metab Dis EEMD Exploration of Endocrine and Metabolic Diseases 2998-2456 Open Exploration Publishing 10.37349/eemd.2024.00020 101420 Correction Correction: A case series of three patients with extensive lung metastatic pheochromocytoma/paraganglioma: evaluation, treatment challenges, and outcomes https://orcid.org/0009-0000-6317-4620 Charles Kailah M. 1 https://orcid.org/0000-0002-1956-6077 Nazari Matthew A. 1 https://orcid.org/0000-0002-1489-2471 Jha Abhishek 1 https://orcid.org/0009-0006-6969-4735 Talvacchio Sara 1 https://orcid.org/0009-0006-9620-6944 Kuo Mickey J. M. 1 2 https://orcid.org/0000-0002-3148-3717 Patel Mayank 1 3 Ling Alexander 4 Alzahrani Ali S. 5 6 https://orcid.org/0009-0007-3887-5303 Prodanov Tamara 1 Derkyi Alberta 1 https://orcid.org/0000-0002-1426-853x Chen Alice 7 Glod John 8 https://orcid.org/0000-0001-9710-4030 Rivero Jaydira Del 9 https://orcid.org/0000-0002-3541-3767 Pacak Karel 1 * 1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA 2Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA 3Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA 4Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA 5Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh 11564, Saudi Arabia 6Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh 11564, Saudi Arabia 7Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA 8Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA 9Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA *Correspondence: Karel Pacak, Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive, Bethesda, MD 20892, USA. karelpacak@yahoo.com 2024 20 12 2024 1 5 244 245 © The Author(s) 2024. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Correction to “A case series of three patients with extensive lung metastatic pheochromocytoma/ paraganglioma: evaluation, treatment challenges, and outcomes” by Charles KM, et al. Explor Endocr Metab Dis. 2024;1:218–233. DOI: 10.37349/eemd.2024.00018

The original version of this article contained errors in the references and their numbering.

The last sentence of the third paragraph in the section “Introduction” contained errors in references. References 25 and 26 have been replaced. The correct version is: “Therefore, treating both pediatric (< 18 years old) and adolescent (10 to 19 years old) metastatic PPGL with extensive pulmonary metastases presents clinical challenges (such as higher incidence of symptoms) which are discussed alongside demonstrative cases and relevant literature [9, 25, 26].”

25. Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, et al. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics. 2006;118:1109–17.

26. De Tersant M, Généré L, Freyçon C, Villebasse S, Abbas R, Barlier A, et al. Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE). J Endocr Soc. 2020;4:bvaa039.

The sixth sentence of the first paragraph in the section “Discussion” contained an error in reference number. Reference number [25] has been replaced with [27]. In the fourth sentence of the fourth paragraph in the “Treatment” section, a citation to Reference [69] has been added.

In addition, the ORCID for author Tamara Prodanov has been added, and there were a number of minor grammatical errors which have been amended. These have been corrected in the PDF and HTML versions of the article.

The original uncorrected PDF can be accessed from https://www.explorationpub.com/uploads/er101418.pdf